{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:15:45Z","timestamp":1764080145409,"version":"3.45.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Program of Henan Province and Chinese Health Committee","award":["No.LHGJ20240023"],"award-info":[{"award-number":["No.LHGJ20240023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01948-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T01:40:37Z","timestamp":1764034837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary 8-oxoGuo as a potential novel evaluation biomarker for patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"26","author":[{"given":"Jingjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanlan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"1948_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/art.41900","volume":"74","author":"E Ginzler","year":"2022","unstructured":"Ginzler E, et al. Phase III\/IV, randomized, fifty-two-week study of the efficacy and safety of belimumab in patients of black African ancestry with systemic lupus erythematosus. Arthritis Rheumatol. 2022;74(1):112\u201323.","journal-title":"Arthritis Rheumatol"},{"key":"1948_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313.","journal-title":"J Autoimmun"},{"issue":"1","key":"1948_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","volume":"80","author":"A Fanouriakis","year":"2021","unstructured":"Fanouriakis A, et al. Update on the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1948_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","volume":"78","author":"D Jesus","year":"2019","unstructured":"Jesus D, et al. Derivation and validation of the SLE disease activity score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity. Ann Rheum Dis. 2019;78(3):365\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1948_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/08916930903374774","volume":"43","author":"A Perl","year":"2010","unstructured":"Perl A. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity. 2010;43(1):32\u201347.","journal-title":"Autoimmunity"},{"issue":"5","key":"1948_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.semarthrit.2017.10.001","volume":"47","author":"G Gulati","year":"2018","unstructured":"Gulati G, Brunner HI. Environmental triggers in systemic lupus erythematosus. Semin Arthritis Rheum. 2018;47(5):710\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"1948_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","volume":"23","author":"VR Moulton","year":"2017","unstructured":"Moulton VR, et al. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615\u201335.","journal-title":"Trends Mol Med"},{"key":"1948_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mrfmmm.2005.04.002","volume":"577","author":"D Br\u00e9geon","year":"2005","unstructured":"Br\u00e9geon D, Sarasin A. Hypothetical role of RNA damage avoidance in preventing human disease. Mutat Res. 2005;577:293\u2013302.","journal-title":"Mutat Res"},{"issue":"2","key":"1948_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clim.2015.07.001","volume":"160","author":"Y Liu","year":"2015","unstructured":"Liu Y, et al. Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clinic immunol (Orlando, Fla). 2015;160(2):319\u201327.","journal-title":"Clinic immunol (Orlando, Fla)"},{"issue":"4","key":"1948_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3233\/JAD-2009-1013","volume":"16","author":"VP Reddy","year":"2009","unstructured":"Reddy VP, et al. Oxidative stress in diabetes and Alzheimer\u2019s disease. J Alzheimers Dis. 2009;16(4):763\u201374.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1948_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","volume":"34","author":"K Daenen","year":"2019","unstructured":"Daenen K, et al. Oxidative stress in chronic kidney disease. Pediatr Nephrol. 2019;34(6):975\u201391.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1948_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/10715762.2012.659248","volume":"46","author":"J Cadet","year":"2012","unstructured":"Cadet J, et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res. 2012;46(4):367\u201381.","journal-title":"Free Radic Res"},{"issue":"11","key":"1948_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00018-010-0277-y","volume":"67","author":"Q Kong","year":"2010","unstructured":"Kong Q, Lin CL. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci. 2010;67(11):1817\u201329.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"1948_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cdd.2014.150","volume":"22","author":"G Filomeni","year":"2015","unstructured":"Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22(3):377\u201388.","journal-title":"Cell Death Differ"},{"key":"1948_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"1948_CR16","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.freeradbiomed.2012.02.016","volume":"52","author":"W Gan","year":"2012","unstructured":"Gan W, et al. Age-dependent increases in the oxidative damage of DNA, RNA, and their metabolites in normal and senescence-accelerated mice analyzed by LC-MS\/MS: urinary 8-oxoguanosine as a novel biomarker of aging. Free Radic Biol Med. 2012;52(9):1700\u20137.","journal-title":"Free Radic Biol Med"},{"key":"1948_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/303181","volume":"2013","author":"B Nie","year":"2013","unstructured":"Nie B, et al. Age-dependent accumulation of 8-oxoguanine in the DNA and RNA in various rat tissues. Oxid Med Cell Longev. 2013;2013:303181.","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"1948_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3109\/10715762.2012.689428","volume":"46","author":"F Shi","year":"2012","unstructured":"Shi F, et al. Oxidative damage of DNA, RNA and their metabolites in leukocytes, plasma and urine of Macaca mulatta: 8-oxoguanosine in urine is a useful marker for aging. Free Radic Res. 2012;46(9):1093\u20138.","journal-title":"Free Radic Res"},{"issue":"11\u201312","key":"1948_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/10715762.2023.2166504","volume":"56","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Urinary 8-oxoGuo as a potential novel evaluation index for patients with nephrotic syndrome. Free Radic Res. 2022;56(11\u201312):691\u20138.","journal-title":"Free Radic Res"},{"issue":"4","key":"1948_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09321","volume":"8","author":"RR Lin","year":"2022","unstructured":"Lin RR, et al. A study on UHPLC-MS\/MS analyses of DNA and RNA oxidative damage metabolites in patients with cervical carcinoma: 8-oxoG in urine as a potential biomarker of cervical carcinoma. Heliyon. 2022;8(4):e09321.","journal-title":"Heliyon"},{"issue":"9","key":"1948_CR21","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1948_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1948_CR23","first-page":"288","volume":"29","author":"D Gladman","year":"2002","unstructured":"Gladman D, Iba\u00f1ez D, Urowitz M. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"4","key":"1948_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein HC, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421\u20136.","journal-title":"JAMA"},{"key":"1948_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cca.2014.04.022","volume":"435","author":"C Burton","year":"2014","unstructured":"Burton C, Shi H, Ma Y. Normalization of urinary pteridines by urine specific gravity for early cancer detection. Clin Chim Acta. 2014;435:42\u20137.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1948_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1373\/clinchem.2004.032292","volume":"50","author":"RC Miller","year":"2004","unstructured":"Miller RC, et al. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin Chem. 2004;50(5):924\u201332.","journal-title":"Clin Chem"},{"issue":"4","key":"1948_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000065220","volume":"22","author":"CR Parikh","year":"2002","unstructured":"Parikh CR, Gyamlani GG, Carvounis CP. Screening for microalbuminuria simplified by urine specific gravity. Am J Nephrol. 2002;22(4):315\u20139.","journal-title":"Am J Nephrol"},{"key":"1948_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070928","author":"H Yu","year":"2021","unstructured":"Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11070928.","journal-title":"Biomolecules"},{"issue":"10","key":"1948_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","volume":"16","author":"DS Pisetsky","year":"2020","unstructured":"Pisetsky DS, Lipsky PE. New insights into the role of antinuclear antibodies in systemic lupus erythematosus. Nat Rev Rheumatol. 2020;16(10):565\u201379.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1948_CR30","first-page":"2063","volume":"182","author":"D Fernandez","year":"2009","unstructured":"Fernandez D, et al. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation. J Invest Med. 2009;182(4):2063\u201373.","journal-title":"J Invest Med"},{"issue":"3","key":"1948_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.3782","volume":"49","author":"J Zhao","year":"2017","unstructured":"Zhao J, et al. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet. 2017;49(3):433\u20137.","journal-title":"Nat Genet"},{"key":"1948_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929520","volume":"13","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus. Front Immunol. 2022;13:929520.","journal-title":"Front Immunol"},{"key":"1948_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180\u20133.","journal-title":"Redox Biol"},{"issue":"8","key":"1948_CR34","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.freeradbiomed.2012.01.009","volume":"52","author":"HE Poulsen","year":"2012","unstructured":"Poulsen HE, et al. RNA modifications by oxidation: a novel disease mechanism? Free Radic Biol Med. 2012;52(8):1353\u201361.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1948_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12640-012-9331-x","volume":"22","author":"A Nunomura","year":"2012","unstructured":"Nunomura A, et al. Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotox Res. 2012;22(3):231\u201348.","journal-title":"Neurotox Res"},{"issue":"2","key":"1948_CR36","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/nbdi.2002.0466","volume":"9","author":"A Kikuchi","year":"2002","unstructured":"Kikuchi A, et al. Systemic increase of oxidative nucleic acid damage in Parkinson\u2019s disease and multiple system atrophy. Neurobiol Dis. 2002;9(2):244\u20138.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1948_CR37","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"A Nunomura","year":"1999","unstructured":"Nunomura A, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease. J Neurosci. 1999;19(6):1959\u201364.","journal-title":"J Neurosci"},{"issue":"9","key":"1948_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/ard.52.9.659","volume":"52","author":"S Bashir","year":"1993","unstructured":"Bashir S, et al. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis. 1993;52(9):659\u201366.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1948_CR39","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00125-017-4510-1","volume":"61","author":"M Sanchez","year":"2018","unstructured":"Sanchez M, et al. Plasma concentrations of 8-hydroxy-2\u2032-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018;61(4):977\u201384.","journal-title":"Diabetologia"},{"issue":"4","key":"1948_CR40","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2337\/dc19-0973","volume":"43","author":"M Sanchez","year":"2020","unstructured":"Sanchez M, et al. Leukocyte telomere length, DNA oxidation, and risk of lower-extremity amputation in patients with long-standing type 1 diabetes. Diabetes Care. 2020;43(4):828\u201334.","journal-title":"Diabetes Care"},{"issue":"3","key":"1948_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2337\/dc12-0998","volume":"36","author":"K Broedbaek","year":"2013","unstructured":"Broedbaek K, et al. Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort study. Diabetes Care. 2013;36(3):669\u201376.","journal-title":"Diabetes Care"},{"issue":"12","key":"1948_CR42","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.2337\/dc11-1620","volume":"34","author":"K Broedbaek","year":"2011","unstructured":"Broedbaek K, et al. Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care. 2011;34(12):2594\u20136.","journal-title":"Diabetes Care"},{"issue":"17","key":"1948_CR43","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","volume":"184","author":"S Caielli","year":"2021","unstructured":"Caielli S, et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021;184(17):4464-4479.e19.","journal-title":"Cell"},{"issue":"12","key":"1948_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41584-019-0332-5","volume":"15","author":"J McHugh","year":"2019","unstructured":"McHugh J. Targeting mitochondrial dysfunction in SLE. Nat Rev Rheumatol. 2019;15(12):700.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1948_CR45","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","volume":"9","author":"A Perl","year":"2013","unstructured":"Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol. 2013;9(11):674\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1948_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1423-0127-21-23","volume":"21","author":"D Shah","year":"2014","unstructured":"Shah D, et al. Oxidative stress and its biomarkers in systemic lupus erythematosus. J Biomed Sci. 2014;21(1):23.","journal-title":"J Biomed Sci"},{"key":"1948_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.genet.36.042602.094806","volume":"36","author":"H Maki","year":"2002","unstructured":"Maki H. Origins of spontaneous mutations: specificity and directionality of base-substitution, frameshift, and sequence-substitution mutageneses. Annu Rev Genet. 2002;36:279\u2013303.","journal-title":"Annu Rev Genet"},{"issue":"2","key":"1948_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0014-5793(94)00583-4","volume":"348","author":"J Lunec","year":"1994","unstructured":"Lunec J, et al. 8-hydroxydeoxyguanosine. A marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett. 1994;348(2):131\u20138.","journal-title":"FEBS Lett"},{"issue":"5","key":"1948_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/10715762.2011.555765","volume":"45","author":"D Shah","year":"2011","unstructured":"Shah D, et al. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res. 2011;45(5):559\u201367.","journal-title":"Free Radic Res"},{"issue":"1","key":"1948_CR50","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/cei.12256","volume":"176","author":"HT Lee","year":"2014","unstructured":"Lee HT, et al. Increased 8-hydroxy-2\u2032-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus. Clin Exp Immunol. 2014;176(1):66\u201377.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1948_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely","year":"2002","unstructured":"Gergely P, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46(1):175\u201390.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1948_CR52","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2183\/pjab.82.278","volume":"82","author":"M Sekiguchi","year":"2006","unstructured":"Sekiguchi M. Molecular devices for high fidelity of DNA replication and gene expression. Proc Japan Acad, Ser B. 2006;82(8):278\u201396.","journal-title":"Proc Japan Acad, Ser B"},{"issue":"2","key":"1948_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3760\/cma.j.issn.0366-6999.20121153","volume":"126","author":"RH Zheng","year":"2013","unstructured":"Zheng RH, et al. Clinical and immunopathological features of patients with lupus hepatitis. Chin Med J (Engl). 2013;126(2):260\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"1948_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.freeradbiomed.2020.03.011","volume":"152","author":"Y Liang","year":"2020","unstructured":"Liang Y, et al. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular disease. Free Radic Biol Med. 2020;152:248\u201354.","journal-title":"Free Radic Biol Med"},{"key":"1948_CR55","doi-asserted-by":"publisher","first-page":"4237812","DOI":"10.1155\/2018\/4237812","volume":"2018","author":"Y Mao","year":"2018","unstructured":"Mao Y, et al. The ratio of plasma and urinary 8-oxo-Gsn could be a novel evaluation index for patients with chronic kidney disease. Oxid Med Cell Longev. 2018;2018:4237812.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"1948_CR56","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00134-003-1761-8","volume":"29","author":"JE Fischer","year":"2003","unstructured":"Fischer JE, Bachmann LM, Jaeschke R. A readers\u2019 guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043\u201351.","journal-title":"Intensive Care Med"},{"issue":"Suppl 3","key":"1948_CR57","first-page":"S497","volume":"61","author":"IA Roy-Garc\u00eda","year":"2023","unstructured":"Roy-Garc\u00eda IA, et al. ROC curves: general characteristics and their usefulness in clinical practice. Rev Med Inst Mex Seguro Soc. 2023;61(Suppl 3):S497-s502.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"4","key":"1948_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015eK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turk J Emerg Med. 2023;23(4):195\u20138.","journal-title":"Turk J Emerg Med."},{"key":"1948_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103180","volume":"106","author":"A Besaratinia","year":"2021","unstructured":"Besaratinia A, Caliri AW, Tommasi S. Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells. DNA Repair. 2021;106:103180.","journal-title":"DNA Repair"},{"key":"1948_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2022.03.007","volume":"183","author":"B Sch\u00f6ttker","year":"2022","unstructured":"Sch\u00f6ttker B, et al. Associations of urinary metabolites of oxidized DNA and RNA with the incidence of diabetes mellitus using UPLC-MS\/MS and ELISA methods. Free Radic Biol Med. 2022;183:51\u20139.","journal-title":"Free Radic Biol Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01948-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01948-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01948-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:05:25Z","timestamp":1764079525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01948-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1948"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01948-w","relation":{},"ISSN":["1591-9528"],"issn-type":[{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"37"}}